Your Cart ( 1 Item )

• Effect of Infliximab on Health-Related Quality of Life and Disease Activity by Body Region in Patients With Moderate-to-Severe Psoriasis and Inadequate Response to Etanercept: Results from the PSUNRISE Trial
  August 2013 | Volume 12 | Issue 8 | Original Article | 874 | Copyright © August 2013
  Robert E. Kalb MD,^a Andrew Blauvelt MD,^b Howard L. Sofen MD,^c Marc Chevrier MD,^d David Amato DO,^d
  Stephen Calabro MS,^d Jim Wang PhD,^e Brad Schenkel MS,^f and Alice B. Gottlieb MD PhD^g
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs